Reportlinker Adds The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
NEW YORK, March 30 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
Summary
GBI Research has released "The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity". The study, which is an offering from the company's Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions – Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.
Scope
- HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
- HPAPIs in key regions – Europe, North America and Asia Pacific.
- Coverage of the product types and therapeutic applications of the global HPAPIs market.
- Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
- Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the global HPAPIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the HPAPIs market.
- Identify macro and micro-economic trends shaping and driving the global HPAPIs market.
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 GBI Report Coverage 9
2.2 Definitions 9
3 Global High Potency Active Pharmaceutical Ingredients Market 10
3.1 Introduction to High Potency Active Pharmaceutical Ingredients 10
3.1.1 Category 1: Low Potency 10
3.1.2 Category 2: Moderate Potency 10
3.1.3 Category 4: High Potency 10
3.2 Global HPAPI Industry Structure 11
3.3 Global HPAPI Industry Challenges 12
3.3.1 Requirement of Large Investments 12
3.3.2 Requirement of Specialized Manufacturing Facilities 12
3.3.3 Necessity of Very Specific Safety and Handling Requirements 12
3.3.4 Need for Tougher Industry Standards 12
3.4 Global HPAPI Market Overview 13
3.5 Global HPAPI Market Drivers 13
3.5.1 The Growth in the Global Anti-Cancer Market is the Major Force Behind the Growing Demand for HPAPIs in the World 13
3.5.2 The Growth of the Targeted Therapy Approach is Driving the Demand for HPAPIs 13
3.5.3 Increasing Number of Applications of HPAPIs is Contributing to Increase in the Demand for HPAPIs Worldwide 13
3.6 Global HPAPI Market Restraints 14
3.6.1 The Global Economic Slowdown is Restricting the Growth of the HPAPI Market 14
3.6.2 Conservative Approach Towards the Acceptance of New and Expensive Drugs is Seen to be a Hindrance to the Growth of the Global HPAPI Market 14
3.6.3 Very High Potency May Create a Roadblock to the Growth of Some HPAPIs 14
3.7 Global HPAPI Market Revenue Forecasts, 2005-2015 14
3.8 Global HPAPI Product Types 15
3.8.1 Types Based on Synthesis Route 15
3.8.2 Types Based On Customer Base 16
3.9 Global HPAPI Market Revenue Share Analysis By Geographies 18
3.10 Global HPAPI Market Revenue Share Analysis by Therapeutic Applications 19
3.11 Global HPAPI Market Opportunity Analysis 20
3.11.1 Strategic Advances in the High Potency Segment 20
3.11.2 Scope for Differentiation in the HPAPI Market 21
4 North America High Potency Active Pharmaceutical Ingredients Market 22
4.1 North America HPAPI Market Overview 22
4.2 North America HPAPI Market Drivers 22
4.2.1 Growth in Oncology is the Major Contributing Factor for the Growth of HPAPI Demand in the Region 22
4.2.2 Increasing Demand for Antibody Drug Conjugates in the Region Facilitates the Growth in HPAPI Demand 22
4.2.3 The Growth of Lifestyle Diseases and Older Age Diseases is Driving the Demand for HPAPI in the Region 22
4.2.4 Increasing Number of Applications is Leading to Higher HPAPI Demand in the Region 22
4.2.5 Large Untapped Market Potential will Increase the HPAPI Market Growth Rate 22
4.2.6 Less Competition from Other Regions Helps the HPAPI Market to Grow In North America 23
4.3 North America HPAPI Market Restraints 23
4.3.1 Economic Slowdown is Restricting the Growth of the HPAPI Market in North America 23
4.3.2 Stringent Cost-Benefit Analysis by Authorities is a Hindrance to the Growth of the HPAPI Market. 23
4.4 North America HPAPI Market Revenue Forecasts 23
4.5 North America HPAPI Market Revenue Share Analysis by Product Types 24
4.6 North America HPAPI Market Revenue Share Analysis By Countries 25
4.7 North America HPAPI Market Competitive Landscape 25
4.8 The US High Potency Active Pharmaceutical Ingredients Market 27
4.8.1 The US HPAPI Market Overview 27
4.8.2 The US HPAPI Market Revenue Forecasts 27
4.9 Canada High Potency Active Pharmaceutical Ingredients Market 28
4.9.1 Canada HPAPI Market Overview 28
4.9.2 Canada HPAPI Market Revenue Forecasts 28
5 Europe High Potency Active Pharmaceutical Ingredients Market 30
5.1 Europe HPAPI Market Overview 30
5.2 Europe HPAPI Market Drivers 30
5.2.1 Growth in Oncology is the Major Force Behind the Growing HPAPI Demand in Europe 30
5.2.2 The Increasing Incidence of Lifestyle and Older Age Diseases in Europe is Giving Rise to Demand for HPAPIs 30
5.2.3 The Growth in the Market for Antibody Drug Conjugates in the Region Strongly Facilitates the Growth of the HPAPI Market 30
5.2.4 Growth in the Number of HPAPI Applications is Widening the Market Demand in the Region 30
5.2.5 Less Competition from Other Regions Helps the HPAPI Market Grow in Europe 30
5.3 Europe HPAPI Market Restraints 31
5.3.1 The Downturn in the Economy Restricts the Growth of the HPAPI Market in the Region 31
5.3.2 Stricter Analyses of the Cost-Benefit Ratios of Drugs by Regulatory Authorities is Becoming an Obstacle to the Growth of the HPAPI Market in the Region 31
5.3.3 Very High Potency of Some HPAPI Compounds May Adversely Affect the Growth in the Region 31
5.4 Europe HPAPI Market Revenue Forecasts 31
5.5 Europe HPAPI Market Revenue Share Analysis By Product Types 32
5.6 Europe HPAPI Market Revenue Share Analysis By Countries 33
5.7 Europe HPAPI Market Competitive Landscape 34
5.8 The UK High Potency Active Pharmaceutical Ingredients Market 35
5.8.1 The UK HPAPI Market Overview 35
5.8.2 The UK HPAPI Market Revenue Forecasts 35
5.9 Germany High Potency Active Pharmaceutical Ingredients Market 37
5.9.1 Germany HPAPI Market Overview 37
5.9.2 Germany HPAPI Market Revenue Forecasts 37
5.10 France High Potency Active Pharmaceutical Ingredients Market 38
5.10.1 France HPAPI Market Overview 38
5.10.2 France HPAPI Market Revenue Forecasts 38
5.11 Italy High Potency Active Pharmaceutical Ingredients Market 39
5.11.1 Italy HPAPI Market Overview 39
5.11.2 Italy HPAPI Market Revenue Forecasts 40
5.12 Spain High Potency Active Pharmaceutical Ingredients Market 41
5.12.1 Spain HPAPI Market Overview 41
5.12.2 Spain HPAPI Market Revenue Forecasts 41
6 Asia Pacific High Potency Active Pharmaceutical Ingredients Market 43
6.1 Asia Pacific HPAPI Market Overview 43
6.2 Asia Pacific HPAPI Market Drivers 43
6.2.1 Strongly Growing Economies and Increasing Healthcare Standards in the Asia Pacific Region Favours the Growth of HPAPI Demand 43
6.2.2 Growth in Demand of Oncology Drugs is Driving the Demand of HPAPIs in Asia Pacific 43
6.2.3 Growth in the Generic Sector HPAPIs 43
6.2.4 The Growing Number of Producers in the Asia Pacific Region is Helping the HPAPI Market to Grow 43
6.3 Asia Pacific HPAPI Market Restraints 43
6.3.1 Restricted Expenditure on New Drugs in the Asia Pacific Countries Forms a Restraint to the Growth of the HPAPI Market 43
6.3.2 Strict Government Policies of The Asian Countries Forms a Hurdle to the Market Growth of HPAPIs in the Asia Pacific Region 44
6.4 Asia Pacific HPAPI Market Revenue Forecasts 44
6.5 Asia Pacific HPAPI Market Revenue Share Analysis by Product Types 45
6.6 Asia Pacific HPAPI Market Revenue Share Analysis by Country 46
6.7 Asia Pacific HPAPI Market Competitive Landscape 47
6.8 Japan High Potency Active Pharmaceutical Ingredients Market 47
6.8.1 Japan HPAPI Market Overview 47
6.8.2 Japan HPAPI Market Revenue Forecasts 47
6.9 India High Potency Active Pharmaceutical Ingredients Market 48
6.9.1 India HPAPI Market Overview 48
6.9.2 India HPAPI Market Revenue Forecasts 49
6.10 China High Potency Active Pharmaceutical Ingredients Market 50
6.10.1 China HPAPI Market Overview 50
6.10.2 China HPAPI Market Revenue Forecasts 50
7 Appendix 52
7.1 Methodology 52
7.1.1 Coverage 52
7.1.2 Secondary Research 53
7.1.3 Primary Research 53
7.1.4 Expert Panel Validation 53
7.2 Units Of Measure 53
7.3 Contact Us 53
7.4 About GBI Research 53
7.5 Disclaimer 54
1.1 List of Tables
Table 1: API Potency Classification Scheme 10
Table 2: Global HPAPI Market, Revenue Forecasts, 2005-2015 15
Table 3: Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009 16
Table 4: Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base, 2009 17
Table 5: Global HPAPI Revenue Share Analysis By Geographies, 2009 19
Table 6: Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications 20
Table 7: North America HPAPI Market, Revenue Forecasts, 2005-2015 24
Table 8: North America HPAPI Market, Revenue Share Analysis By Product Types, 2009 25
Table 9: North America HPAPI Market, Revenue Share Analysis By Countries, 2009 25
Table 10: North America HPAPI Market, Revenue Share Analysis By Companies, 2009 26
Table 11: The US HPAPI Market, Revenue Forecasts, 2005-2015 28
Table 12: Canada HPAPI Market, Revenue Forecasts, 2005-2015 29
Table 13: Europe HPAPI Market, Revenue Forecasts, 2005-2015 32
Table 14: Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009 33
Table 15: Europe HPAPI Market, Revenue Share Analysis By Countries 34
Table 16: Europe HPAPI Market, Revenue Share Analysis By Companies, 2009 35
Table 17: The UK HPAPI Market Revenue Forecasts, 2005-2015 36
Table 18: Germany HPAPI Market Revenue Forecasts, 2005-2015 38
Table 19: France HPAPI Market, Revenue Forecasts, 2005-2015 39
Table 20: Italy HPAPI Market Revenue Forecasts, 2005-2015 41
Table 21: Spain HPAPI Market Revenue Forecasts, 2005-2015 42
Table 22: Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015 45
Table 23: Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009 46
Table 24: Asia Pacific HPAPI Market, Revenue Share Analysis By Country, 2009 47
Table 25: Japan HPAPI Market, Revenue Forecasts, 2005-2015 48
Table 26: India HPAPI Market, Revenue Forecasts, 2005-2015 50
Table 27: China HPAPI Market, Revenue Forecasts, 2005-2015 51
1.2 List of Figures
Figure 1: Global HPAPI Market, Value Chain, 2009 11
Figure 2: Global HPAPI Market, Revenue Forecasts, 2005-2015 15
Figure 3: Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009 16
Figure 4: Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base, 2009 17
Figure 5: Global HPAPI, Product Types, 2009 18
Figure 6: Global HPAPI Market, Revenue Share Analysis By Geographies, 2009 18
Figure 7: Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications 20
Figure 8: North America HPAPI Market, Revenue Forecasts, 2005-2015 23
Figure 9: North America HPAPI Market, Revenue Share Analysis By Product Types, 2009 24
Figure 10: North America HPAPI Market, Revenue Share Analysis By Countries, 2009 25
Figure 11: North America HPAPI Market, Revenue Share Analysis By Companies, 2009 26
Figure 12: The US HPAPI Market, Revenue Forecasts, 2005-2015 27
Figure 13: Canada HPAPI Market, Revenue Forecasts, 2005-2015 29
Figure 14: Europe HPAPI Market, Revenue Forecasts, 2005-2015 31
Figure 15: Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009 32
Figure 16: Europe HPAPI Market, Revenue Share Analysis By Countries, 2009 33
Figure 17: Europe HPAPI Market, Revenue Share Analysis By Companies, 2009 35
Figure 18: The UK HPAPI Revenue Forecasts, 2005-2015 36
Figure 19: Germany HPAPI Market Revenue Forecasts, 2005-2015 37
Figure 20: France HPAPI Market, Revenue Forecasts, 2005-2015 39
Figure 21: Italy HPAPI Market Revenue Forecasts, 2005-2015 40
Figure 22: Spain HPAPI Market Revenue Forecasts, 2005-2015 42
Figure 23: Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015 44
Figure 24: Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009 45
Figure 25: Asia Pacific HPAPI Market, Revenue Share Analysis By Country, 2009 46
Figure 26: Japan HPAPI Market, Revenue Forecasts, 2005-2015 48
Figure 27: India HPAPI Market, Revenue Forecasts, 2005-2015 49
Figure 28: China HPAPI Market, Revenue Forecasts, 2005-2015 51
Figure 29: GBI Research Methodology, 2010 52
Companies mentioned
To order this report:
Pharmaceutical Industry: The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article